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Generation of human organoids from induced pluripotent stem cells (iPSCs) offers exciting possibilities
for developmental biology, disease modelling and cell therapy. Significant advances towards those goals
have been hampered by dependence on animal derived matrices (e.g. Matrigel), immortalized cell lines
and resultant structures that are difficult to control or scale. To address these challenges, we aimed to
develop a fully defined liver organoid platform using inverted colloid crystal (ICC) whose 3-dimensional
mechanical properties could be engineered to recapitulate the extracellular niche sensed by hepatic
progenitors during human development. iPSC derived hepatic progenitors (IH) formed organoids most
optimally in ICC scaffolds constructed with 140 mm diameter pores coated with type I collagen in a two-
step process mimicking liver bud formation. The resultant organoids were closer to adult tissue,
compared to 2D and 3D controls, with respect to morphology, gene expression, protein secretion, drug
metabolism and viral infection and could integrate, vascularise and function following implantation into
livers of immune-deficient mice. Preliminary interrogation of the underpinning mechanisms highlighted
the importance of TGFb and hedgehog signalling pathways. The combination of functional relevance with
tuneable mechanical properties leads us to propose this bioengineered platform to be ideally suited for a
range of future mechanistic and clinical organoid related applications.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).; IH, iPSC derived hepatic progenitors; FDA, food and drug administration; TGFb, transforming growth factor beta; 3D,
, polyethylene glycol; ECM, extracellular matrix; Col, collagen; Fn, fibronectin; Ln, laminin; CK19, keratin 19; ECAM,
ein; ASGR1, asialoglycoprotein receptor 1; ALB, albumin; HNF4a, hepatocyte nuclear factor 4-alpha; RT-qPCR, reverse
; 2D, two-dimensional; RNA-seq, RNA-sequence; DE, iPSC derived definitive endoderm; PCA, principle component
bile-salt efflux pump; ZO-1, tight junction protein 1; CLF, cholyl-lysyl-flourescence; TGZ, Troglitazone; HCV, hepatitis C
avenger receptor class B type 1; LDLR, low-density lipoprotein receptor; HSGP, heparin sulfate glycoprotein; H&E,
uman umbilical endothelial cell; MSC, mesenchymal stem cell.
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Induced pluripotent stem cells offer exciting new possibilities in
developmental biology, disease modelling and transplantation.
Comprehensive realization of that promise is likely to require
consolidation with other emerging technologies such as 3D cell
culture. Along those lines, hepatic progenitor cells derived from
iPSCs [1] and primary tissue [2] were recently shown to form
“Organoids” (self-organising miniaturized 3D structures resem-
bling liver tissue) following 3D culture initiated by Matrigel.
Organoid generation using Matrigel has similarly been demon-
strated across a broad range of tissue types including intestine,
kidney and brain [3e5], underlining the importance of this novel
approach across the stem cell field. Downstream applications are
however limited by the use of Matrigel which is poorly character-
ized, highly variable and of mouse origin [6]. A bioengineered
substitute is therefore essential and was recently reported for in-
testinal organoid generation [7]. A similar bottom up engineering
approach for liver organoid production is urgently needed. We
recently developed a novel hepatocyte culture system composed of
a 3D-hexagonally arrayed inverted colloidal crystal (ICC) scaffold
[8]. In comparison to other 3D culture systems, the ICC boasts
several advantages. These include being made from an FDA
approved material, polyethylene glycol (PEG), that can be func-
tionalized with select ECM proteins or varied in mechanical stiff-
ness, a highly uniform architecture which incorporates size-
selectable pores to facilitate tissue interconnection across the
whole module whilst retaining uniform nutrient penetration to all
cells and finally, being transparent to provide an easy means of
viewing cells and intra-cellular fluorescence over time. Exploiting
these properties, we were able to facilitate induction of organoid
structures with advanced liver function in primary human fetal
liver cells cultured in ICC's [9]. Lack of donor material, ethical
constraints and biological heterogeneity however make further
progress difficult with human fetal cells. We therefore turned to the
recently established technology of human iPSC-derived hepato-
cytes [10,11], as a good biological approximation to human fetal
liver cells but not limited by the same constraints cited above, to
explore their potential for organoid generation.
2. Materials & methods
2.1. Study design
The overall objective of this study was to test whether organoids
bioengineered in ICC scaffolds exhibited a more physiologically
relevant liver phenotype compared to conventional 2D or 3D
(Matrigel and Spheroid) models. iPSC-derived hepatic progenitors
(IH) differentiated from the same parental line were therefore
matured in four different in vitro models (ICC, 3D Matrigel,
Spheroid and 2D) for 14 days and compared. Measurement tech-
niques to compare the three models were designed to characterize
two major endpoints: morphology (organoid formation) and
function (gene expression, protein expression, liver specific func-
tions and in vivo behavior). In transplant experiments, littermate
animals were randomly assigned to experimental groups and
analysis of samples was performed blindly. Studies were repeated
at least three times.
2.2. Cells
All human tissues were collected with informed consent
following ethical and institutional guidelines. Freshly isolated he-
patocytes were obtained from Triangle Research Labs (TRL) and
Human Developmental Biology Resource (HDBR) UniversityCollege London (UCL). Fetal hepatocytes were obtained from 16 to
20 week old fetuses (HDBR), dissociated as previously described
[12]. Three different human iPSC lines were used to generate he-
patic progenitors (IH) for these experiments: [1,10] (https://
stemcells.nindsgenetics.org/), [11] the latter of which is consid-
ered to be of ‘clinical grade’ and thereby potentially suitable for
future human therapy.
2.3. ICC fabrication
Sacrificial crystal lattices were constructed on a rhombus PDMS
mold with 17mmx15mm diagonal lengths and 2mm depth using
polystyrene beads with diameter of 40 mm, 60 mm, 100 mm, or
140 mm (Duke Scientific) and annealed under 140 C for 1.5 h. Lat-
tices were then infiltrated with precursor solution of 50 %w/v
polyethylene glycol-diacrylate (PEGDA, Alfa Aesar), 10 %w/v
acrylate-PEG-N-hydroxysuccinimide (Laysan Bio Inc, AL) and 1 %w/
v photoinitiator (Irgacure® 2959, BASF, Switzerland) in DI water.
The precursor solution underwent free-radical induced polymeri-
zation under 75W xenon ultraviolet (UV) light source (Oriel In-
struments, Mountain View, CA) for 10min. After polymerization,
the polystyrene sacrificial lattice was removed by tetrahydrofuran
treatment for 2 h. The resulting ICC hydrogel scaffolds were equil-
ibrated in deionized water and conjugated with appropriate ECM
proteins, such as 100 mg/mL Collagen I (Col-I, Sigma), 50 mg/mL
Fibronectin (Fn, RnD), and 10 mg/mL Laminin 521 (Ln-521, Bio-
lamina) (Fig. 1A). The final tubular ICC scaffolds for 96 well plate
format culture were created using 6mm biopsy punch.
2.4. iPSC-derived liver organoid culture
iPSC-derived hepatic progenitors (IH) were generated using our
established protocol (Fig. 1B) [13]. To generate iPSC liver organoids,
we suspended approximately 0.5 106 IH cells in Hepatozyme
medium (Life Technologies), supplemented with Oncostatin M
0.01 mg/ml (Peprotech) and Hepatocyte Growth Factor 0.05 mg/ml
(Peprotech) with the final cell density of 125 106 cells/ml (Fig.1C).
Approximately 4 ml cell suspension was then pipetted onto top and
bottom surfaces of partially dehydrated ICC scaffolds and placed in
an incubator for 30min without media to minimize cell loss and
maximize cell attachment. Cell-laden ICC scaffolds were then
transferred to a new 96-well plate for culture and media were
refreshed at 4 h post-seeding to remove excessive cells that are not
attached to surface or established cellular clusters. Cells were left
for a further 14 days to mature. Media was refreshed every two
days. 2D controls were generated using IH cells seeded into stan-
dard 48 well plate tissue culture plastic plates coated with the same
ECM proteins and cultured with the same reagents as used for ICC
culture.
2.5. Generation of IH-spheroids
A single cell suspension of IH was prepared and 0.3 106 cells
were seeded per well of a 24-well Aggrewell-400 (STEMCELL
Technologies, Vancouver, Canada). Aggrewell plates were prepared
as recommended by the supplier. Centrifugation at 200G for 3min
was carried out to deposit cells into the microwells of the plate.
2.6. Immunofluorescence staining and imaging
After fixationwith 4% paraformaldehyde, cells were blocked and
permeabilized in 1% w/v bovine serum albumin (BSA, Sigma-
Aldrich), 10% donkey serum (Life Technologies) and 0.1% Triton)
for 30min at RT. For nuclear antigens, cells were treated with 0.5%
Triton (Sigma-Aldrich), then primary antibodies, CTNNB (mouse,
Fig. 1. Bioengineering liver organoids using ICC scaffold and iPSC-derived hepatic progenitor (IH). (A) Schematic illustration of ICC fabrication using a range of sacrificial mono-
dispersed beads and ECM proteins for stem cell niche modulation. (B) Schematic of human iPSC-derived hepatic progenitors differentiation protocol. (C) Schematic of bioengi-
neering liver organoids using IH and ICC in three main steps, cell seeding, cell attachment (Phase I) and organoid formation (Phase II). Confocal micrographs of human fetal liver
cells (Fetal; CTNNB green; CK19 red) demonstrating the two-phase organoid formation in Col-I coated ICC with 140 mm pore size. Arrowheads indicate cells lining surface of ICC;
asterisks represent cells forming clusters. Scale bar, 100 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this
article.)
S.S. Ng et al. / Biomaterials 182 (2018) 299e311 3011:100; bdbiosciences), CK19 (rabbit, 1:500; abcam), HNF4a (rabbit,
1:100; abcam), AFP (mouse, 1:100; abcam) and ALB (goat, 1:100;
Bethyl), ASGR1 (mouse, 1:100; Thermo Fisher Scientific), COL1
(rabbit, 1:500; abcam), Vimentin (rabbit, 1:200; abcam); CD44
(mouse, 1:200 abcam), CD31 (rabbit, 1:50; abcam); Col-X (mouse,
1:250; abcam), MRP2 (mouse, 1:200; abcam), ZO-1 (mouse, 1:100;
abcam), CD26 (rabbit, 1:100; abcam), Pan-Cadherin (mouse, 1:100;
Sigma), Claudin 1 (rabbit, 1:100; abcam), Occludin (mouse, 1:100;
abcam), Stem121 (mouse, 1:100; Cellartis), phosphor-SMAD2/3
(rabbit, 1:100; Cell signalling technology) and GLI1 (rabbit, 1:100;
abcam) were applied for overnight at 4 C. After washes, cells were
then incubated with Alexa 647, Alexa 568, Alexa 488 conjugated
secondary antibodies or 488-Phalloidin (1:250; Life Technologies).
Samples were counterstained with DAPI (NucBlue, Life Technolo-
gies). Confocal micrographs were captured using Nikon Ti spinning
disk confocal microscope equipped with Andor Neo camera and
images were processed by NIS-element software.2.7. Bright field imaging
Bright field imaging was captured using Leica DMIL LED
equipped with Leica DFC3000 G camera and images processed by
LAS X software.2.8. Live/dead staining
Fluorescine diacete (FDA) (Sigma-Aldrich, St. Louis, USA) and
cell-impermeant ethidium homodimer-1 (EthD-1) (Thermo Fisher
Scientific, Waltham, USA) were used as recommended by the
supplier for staining of viable and dead cells. Spheroids and alginate
encapsulated cells were incubated in 4 mM EthD-1 for 35min,
washed with Hank's Balanced Salt Solution (HBSS) containing cal-
cium (Thermo Fisher Scientific, Waltham, USA), then incubated in
50 mg/ml FDA for 90 s, and finally washed 5 times with HBSS before
imaging.
2.9. Cell number quantification
Double stranded DNAwas collected, quantified and interpolated
from standard curve plotted using a range of known cell number as
illustrated by Quant-iT™ PicoGreen™ dsDNA Assay Kit (Thermo-
Fisher Scientific).
2.10. Human albumin enzyme-linked immunosorbent assay (ELISA)
Albumin secretion of all different cell types was assessed using
the Human Albumin Quantitation Set (Bethyl Laboratories Inc)
following manufacturer's instructions.
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IH-ICC or animal explants were fixed in 10% formalin buffer
saline for two days then dehydrated and paraffin wax infiltrated
using Excelsior™ AS Tissue Processor. After embedded, sectioned
(5 mm), and stained usingMouse and Rabbit Specific HRP/AEC (ABC)
Detection IHC Kit (abcam) using antibody CK19 (rabbit, 1:200;
abcam), EPCAM (mouse,1:200; abcam), ALB (mouse,1:100; abcam)
and CD31 (mouse, 1:100; Dako) then counterstained with haema-
toxylin (abcam). Mounted slides were imaged using NanoZoomer
(Hamamatsu).
2.12. Image analysis
To analyse the confluency and cluster morphology of cells in ICC,
selected images of F-actin staining were reconstructed using
maximum intensity projection. The confluency index ¼(Cc/
Cp 100%) is introduced to quantify the proportion of the ICC
surface covered by cell attachment bymeasuring the circumference
of cell lining (Cc) over the overall circumference of pores in ICC (Cp).
The cluster index ¼ (Kc/Kp 100%) is introduced to quantify the
number of cell cluster in each pore (Kc) against the total number of
pores (Kp) in the frame.
2.13. Fluorescence-activated cell sorting (FACS) staining and
analysis
Cells were dissociated from organoid or 2D culture using TrypLE
reagent (Thermo Fisher Scientific) and stained using the same
condition as immunofluorescence staining protocol stated above.
Flow analysis performed using FACSCanto II (BD) and analyized
using FlowJo (LLC).
2.14. Quantitative real-time PCR (RT-qPCR) analysis
Total RNA was harvested using TRIZOL reagent (Sigma), treated
with DNase (Promega) and phenol/chloroform purified. For each
sample 0.5 mg of total RNA was reverse transcribed using Super-
Script VILO cDNA Synthesis kit (Thermo Fisher Scientific). A typical
RT-PCR reaction contained 10 ng of sample cDNA, 0.0075 ml of in-
dividual forward and reverse primer each at 100 mM stock, 5 ml
Taqman Universal Master mix (Applied Biosystems), 1 ml Taqman
target probe (supplementary Figs. 5) and made up to 10 ml with
nuclease-free water. Real time PCR reactions were amplified for 40
cycles on a CFX384 Touch™ Real-Time PCR Detection System
(Biorad) in triplicate and normalized to ACTB in the same run.
2.15. Heat map generation, gene set enrichment analysis, functional
network analysis and top canonical pathway analysis
Heat maps were generated from Bulk RNAseq data collected
from three Human Fetal Livers, three Human Adult Livers and three
iPSC-derived hepatocytes harvested at definitive endodermal stage
from the BOB cell line. The three fetal livers included 14pcw, 16pcw
and 20pcw. The three adult Livers were Female 18yrs, Male 43yrs
and Male 13yrs. RNAwas extracted using TRI reagent. Starting with
1 mg input total RNA, Ribosomal RNAwas removed using Ribo-Zero
Gold rRNA Removal kit (Illumia). Sequencing libraries were pre-
pared using NEBNext® Ultra™ Directional RNA Library Prep Kit for
Illumina (N.E.B) using 100 ng rRNA depleted sample and sequenced
on a HiSeq 2500 system in Rapid run mode (Illumina) following a
standard protocol. All libraries generated between 15 and 25M
reads. Reads were mapped to GRCh38 reference genome using
Bowtie2. Raw counts and normalized gene expression was gener-
ated using HT-Seq and DESEq2 packages respectively. Heat mapwas generated using R (http://www.R-project.org) (R Development
Core Team, 2008). Heat maps represent average DESEq2 normal-
ized gene expression values of three independent biological sam-
ples. Gene set enrichment analysis was performed on normalized
RNA sequencing gene expression data through GSEA software27,28
run using the hallmarkMSigDB gene set collections. To examine the
role of IH-ICC organoid in cell polarity and bile acid synthesis and
metabolism, we cross-referenced the differential gene expression
with the Gene Ontology (GO) annotations and predict the protein
interactions networking using Search Tool for the Retrieval of
Interacting Genes (STRING). Top canonical pathways analysis was
performed using Ingenuity Pathway Analysis (IPA) (Qiagen).
2.16. GLuc HCVcc infection and analysis
GLuc HCVcc is a full length Gaussia luciferase reporter virus
Jc1FLAG2 (p7-nsGluc2A)35 infectious Jc1 genome that allows us to
monitor viral infection in real time. Knock down HCVcc is the
corresponding polymerase-defective mutant that inhibits viral
replication. Respective viral stocks were prepared using electro-
poration on Huh 7.5 cells as described [14]. Infectious titers of
HCVcc inocula were determined using Huh 7.5 cells as described.
Cultures were inoculated for 3 h with HCVcc then washed exten-
sively with PBS and fed with culture media.
2.17. Cholyl-lysyl-fluorescein (CLF) transportation
5 mM CLF (Corning) was incubated with cultures treated with
10 mM Troglitazone (TGZ, Sigma) and 0.02% DMSO vehicle control
for 45min. The cultures were then washed five times with PBS and
incubated in culture media for 30min before confocal imaging. For
CLF quantification, cultures where treated by cell lysis buffer
(Sigma) and fluorescence intensity was measured using plate
reader.
2.18. Animal experiments
All animal experiments were performed in accordance with UK
Home Office regulations (UK Home Office Project License number
PPL 70/8702). Immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ
(NSG)micewhich lack B, Tand NK lymphocyteswere bred in-house
with food and water available ad libitum pre- and post-procedures.
A mix of male and female animals were used, aged approximately
6e8 weeks. An incisionwasmade in the capsule of the caudate lobe
of the liver and a ‘pocket’ was created by raising a flap of capsule on
either side of the incision. The scaffold was slid into the pocket and
covered by the capsular flaps. The left lobe of the liver was then
allowed to cover the site of the transplant.
2.19. Statistical analysis
N in the paper represents the number of biological replicates of
each batch of liver specific differentiation performed using three
iPSC lines. Statistical significance (p< 0.05) was determined by
using Student's T-test (assume Gaussian distribution, two-tailed) or
One-way ANOVA followed by Tukey's posthoc test. .
3. Results
3.1. iPSC-derived hepatic progenitors (IH) form organoids
analogous to fetal liver derived primary cells following culture in ICC
scaffolds
Human fetal liver cells seeded into ICC scaffolds with the 140 mm
pore size and type I collagen (Col-I) coating attach as a single cell
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morphologically stable, interconnected clusters (Phase II - days 7
post-seeding onward) (Fig. 1C). The resultant 3D structure re-
sembles a mini-liver or hepatic ‘organoid’ with demonstrated
advanced liver function [9]. We therefore hypothesized that orga-
noid formation was critically dependent upon the translation of
specific ‘cell-matrix’ and ‘cell-cell’ signals by hepatic progenitors in
a manner which could be recapitulated using iPSC-derived pro-
genitors (IH) (Supplementary Fig. 1). To test this hypothesis, we
therefore engineered a library of ICC scaffolds to evaluate the ef-
fects of selected extracellular matrix protein (ECM) coatings and
pore sizes on IH-organoid forming ability (Fig. 2). Of the ECM
coatings tested, only cells seeded into Col-I were able to attach and
self-organize into interconnected clusters throughout the scaffold
as observed with primary fetal progenitors (Fetal) (Fig. 2AeC,
Supplementary Fig. 2). Cells seeded into fibronectin (Fn) attached
but failed to establish confluency whilst cells seeded into laminin-
521 (Ln-521) attached and remained as such throughout the cul-
ture. The observed organoid forming ability was matched by
functional parameters of liver tissue such as albumin secretion and
hepatic gene expression (Fig. 2D and Supplementary Fig. 3). Having
established the optimal ECM coating, we next went on to assess the
effects of cell-cell interaction by testing type I collagen coated ICC's
composed from different pore sizes. Accordingly, a 140 mmpore size
was found to be optimal for organoid formation based on
morphology and again confirmed by hepatic function and gene
expression (Fig. 2EeH). Through this extensive series of experi-
ments, we observed IH seeded into type I collagen coated ICC
scaffolds of 140 mm pore size best replicated the results seen with
primary fetal liver cells with minimal cell lost and death
(Supplementary Figs. 4-5). Importantly, the two-phase process of
organogenesis was observed only with IH and primary fetal cells
but did not occur with primary adult or cancer-like hepatocytes
(Huh 7.5 and HepG2) (Supplementary Fig. 6).
3.2. IH-ICC derived organoids demonstrate morphological and
transcriptomic characteristics of human liver
To evaluate the anatomical similarity between organoids
derived from iPSC-hepatic progenitors cultured in ICC scaffolds (IH-
ICC) and human liver, we first used a combination of histochemical
and immunofluorescence staining to characterize the organoid
tissue across the two phases of organogenesis previously described
(Fig. 3AeB and Supplementary Figs. 7-10). In Phase I, hepatic pro-
genitor markers such as keratin 19 (CK19), epithelial cell adhesion
molecule (EPCAM) and alpha-fetoprotein (AFP) proteins were
expressed in cells lining the circumference of the scaffold's pores.
Following onset of organogenesis in Phase II, these (CK19, EPCAM,
AFP, EdU)þve progenitor cells were retained at the periphery of the
organoid, with more mature cells, characterized by protein
expression of asialoglycoprotein receptor 1 (ASGR1), albumin
(ALB), and hepatocyte nuclear factor 4-alpha (HNF4A), forming and
remodelled by the cell secreted type I collagen (Col-I) at the centre.
These datawere then validated quantitatively using flow cytometry
(Fig. 3C) and by RT-PCR for gene expression (Fig. 3D), allowing us to
conclude that organoids became established with unique cellular
arrangement in a structure reminiscent of the hepatic buds seen in
embryonic [15] and regenerating human liver tissue [16]. This
anatomical distributionwas not observedwhen IHwere cultured in
Matrigel, the current gold standard in the field, or the conventional
3D spheroid model. Embedding in Matrigel, IH established lumen-
containing colonies, expressing mature hepatic markers
(Supplementary Fig. 11). On the contrary, IH formed solid cell
clusters in spheroid model with more mature cells segregated on
the outer layer (Supplementary Fig. 12). Both Matrigel and spheroidmodels demonstrated functional properties (protein secretion and
metabolic activity) significantly higher compared to 2D culture but
notably not significantly higher than in ICC culture (Supplementary
Fig. 13).
Having validated the organoid structure in our new bio-
engineered platform, we next sought to characterize the global
transcriptomic changes during the different phases of organogen-
esis using RNA-seq. To do this, organoids were compared to iPSC
derived definitive endoderm (DE), 2D cultured IH, primary adult
and primary fetal hepatocytes. Principle component analysis (PCA)
on DE, 2D, ICC, fetal and adult samples (Fig. 4A) shows that IH have
a distinct transcriptional phenotype when cultured in ICC over 2D
conditions. A liver-specific gene-set of 296 genes were selected to
perform unbiased hierarchical clustering and visualized by heat-
map. The unbiased hierarchical clustering revealed that the liver-
specific transcriptional signature of organoids was positioned in
the cluster next to adult and fetal liver, with higher similarity to
fetal than adult, whereas 2D cells clustered next to DE (Fig. 3E).
Overall 489 genes were found to be significantly upregulated in
both organoid and 2D samples, with 1349 and 179 genes uniquely
upregulated in organoid and 2D systems respectively (Fig. 4B).
Gene set enrichment and Ingenuity Pathway (IPA) analysis of the
upregulated genes revealed some liver-specific functions such as
xenobiotic and bile acid metabolism to be enriched in both orga-
noid and 2D platforms (Supplementary Fig. 14 and Supplementary
Tables 1 and 2) but the majority of liver-specific functions such as
cholesterol homeostasis, glycolysis, fatty acid metabolism and
protein secretionwere found to be uniquely enriched in IH-ICC. The
top 18 upregulated organoid specific hepatic genes were validated
by qPCR (Supplementary Table 3 and Fig. 4C).
Cumulatively, these data confirm our previous morphological
observations suggesting IH derived progenitors seeded into ICC
scaffolds form organoid structures whose transcriptomic and pro-
tein expression profiles resemble human liver structures.3.3. IH-ICC organoids are functionally closer to human liver
Upon extended interrogation, we discovered that IH-organoids
are functionally more advanced than the 2D model in albumin
production and basal activities of drug metabolizing cytochrome
P450 isoforms CYP3A4 and CYP2C9 (Fig. 5A and B). Similarly,
capability for transporting bile salts also appeared more advanced.
Hepatic polarity proteins critical for the structure of bile canaliculi
such as multidrug resistance protein 2 (MRP2), tight junction pro-
tein 1 (ZO-1), CD26 and pan-cadherin were all expressed (Fig. 5C
and Supplementary Fig. 15). Bile salt efflux was then validated
through uptake and accumulation of synthetic bile acid, cholyl-
lysyl-fluorescence (CLF), in bile canaliculi-like regions (Fig. 5D).
The ability of organoids to retain CLF was eliminated when treated
with the BSEP inhibitor, Troglitazone (TGZ), as indicated by fluo-
rescence measurement (Fig. 5E).
The cell polarity and bile acid secretory function of organoid was
further validated by cross-referencing the uniquely upregulated
differentially expressed genes in ICC with GO categories (GO
0007163: establishment or maintenance of cell polarity; GO
0000902: cell morphogenesis; GO 0007010: cytoskeleton organi-
zation; GO 0006699: bile acid biosynthetic process and GO
0008206: bile acid metabolic process) followed by functional
network analysis using STRING on selected enriched gene sets
(Fig. 5F and Supplementary Figs. 16-18) [17]. The 28 genes uniquely
upregulated in organoids could be assigned to the key KEGG
pathways such as regulation of actin cytoskeleton, focal adhesion
and tight junction required for cell polarization (Fig. 5G).
Fig. 2. Characterizing the effects of pore size and ECM proteins on liver organoid formation in ICC scaffold. (A) Confocal micrographs of IH (CTNNB, green; CK19, red) following
seeding into non-coated (Naked), Fibronectin (Fn), Laminin 521 (Ln-521), and Collagen I (Col-I) coated ICC's. (B) Quantification of cellular attachment (confluency) and cluster
formation (cluster) ability seen across different ECM's during Phase I and II. (C) Cell number relative to initial cell seeding number in Phase I and II. (D) Albumin secretion rate of IH
seeded in different ECM coated ICC in Phase II (E) Bright field images revealing the morphologies of IH in ICC with different collagen coated pore sizes (40 mm, 60 mm, 100 mm and
140 mm) and the respective (F) morphological quantitation and (G) relative cell number in Phase I and II. (H) Albumin secretion rate of IH seeded in ICC with different pore sizes in
Phase II. Arrowheads indicate cells lining surface of ICC; asterisks represent cells forming clusters. Scale bar, 100 mm. Mean ± sd, N ¼ 4. *p < 0.05; **p < 0.005; ***p < 0.0005;
****p < 0.0001; ns non-significant. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 3. Morphological and transcriptomic characterization of IH-ICC organoids. (A) Histochemical images demonstrating morphogenesis of IH from a single cell layer (Phase I top
panel; scale bar, 100 mm) to organoids (Phase II bottom panel; scale bar, 50 mm) occurs in conjunction with differential protein expression of developmental markers CK19 (left),
EPCAM (middle) and ALB (right). (B) Confocal micrographs highlighting upregulated protein expression of mature (ALB, ASGPR1, COL1) hepatic markers occurs in conjunction with
down regulation of immature (CK19 and AFP) markers during transition of IH from Phase I (top panel; scale bar, 100 mm) to Phase II (bottom panel; scale bar, 100 mm) organoids. (C)
FACS histogram and mean fluorescence intensity (MFI) analysis demonstrating hepatic maturation kinetics of IH in ICC vs 2D culture (N¼ 4). (D) Differential gene expression (by RT-
PCR) of selected genes reveals a more mature hepatic signature of IH in ICC vs. 2D culture (N¼ 8). (e) Bi-clustering heatmap of 296 liver-specific genes across different primary
(adult & fetal liver) and IH (DE, 2D & ICC) samples. Samples are linked by the dendrogram above to show the similarity of their gene expression patterns. Mean ± sd, *p < 0.05;
**p < 0.005; ***p < 0.0005; ****p < 0.0001; ns nonsignificant.
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Fig. 4. The transcriptomic analysis of liver organoid in ICC. (A) Principle component analysis of RNA-seq data demonstrating the proximity of gene expression variance in 2D plot.
(B) Venn diagrams showing the number of up and downregulated gene in ICC and 2D with respect to DE. (C) RT-PCR validation on top 18 liver-specific genes identified by RNA-seq
analysis (N¼ 3) Mean ± sd.
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vascularised tissue following transplantation
Next, to test the ICC organoid's suitability for disease modelling
we investigated whether organoids expressed HCV host factors andwere susceptible to HCV infection. Transcriptional analysis revealed
expression of HCV host factors were enriched in organoids and
more closely resembled the expression signature of primary he-
patocytes (Fig. 6A). This included genes responsible for HCV entry
such as claudin 1 (CLDN1) occludin (OCLN) scavenger receptor, class
Fig. 5. Functional validation of organoids. (A) Albumin secretion rate of IH-ICC vs. 2D (N¼ 8). (B) Basal metabolic activity of Cytochrome P450 isoforms CYP3A4 and CYP2C9 in IH-
ICC vs 2D (N¼ 8). RLU, relative luminescence unit. (C) Confocal micrographs showing expression of hepatocyte polarity markers (MRP2, ZO-1, CD26 and Pan-Cadherin) in IH-ICC
organoids. Scale bar, 50 mm. White arrowhead points to apical region. (D) Accumulation of Cholyl-L-lysyl-fluorescein (CLS) in IH-ICC organoids after 40min of CLF incubation
followed by 40min of washing. White arrowhead points to the CLF accumulation. (E) Effect of adding Troglitazone (TGZ) to CLS retention in IH-ICC (N¼ 4). (F) A list of uniquely
upregulated genes in IH-ICC vs 2D that involved in establishment and maintenance of cell polarity. FC, fold change. (G) The STRING functional network predicted the associations
between proteins (nodes) from regulated genes involved in cell polarity in IH-ICC. The cluster analysis was performed using KMEANS clustering algorithms. Mean ± sd, *p < 0.05;
**p < 0.005; ***p < 0.0005; ****p < 0.0001; ns nonsignificant.
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and heparin sulfate glycoprotein (HSGP). In addition, a wide range
of apoliproteins responsible for packaging and interacting with
viral particles were highly expressed [18]. Immunofluorescence
staining showed claudin 1 and occludin appear to localize at theinterface of cell-cell junctions, similar to ZO-1 and MRP2 (Fig. 6B
and Supplementary Fig. 19). These results are in agreement with
the claudin 1 distribution seen in HepG2 and Huh-7 cell models
permissive to HCV entry [19,20]. We next infected organoids with
genotype 2a HCV reporter virus expressing secreted Gaussia
Fig. 6. Disease modelling and in vivo transplantation. (A) Heatmap and hierarchal clustering comparing expression of 12 genes involved in encoding HCV entry and assembly in IH-
ICC vs 2D vs primary (adult, fetal) liver. (B) Confocal imaging showing expression of claudin 1 and occludin in IH-ICC organoids. Scale bar, 100 mm. White and red arrowheads point
to apical and lateral regions respectively. (C) HCV expression of IH-ICC vs 2D following infection with HCV reporter virus expressing secreted GLuc (HCVcc, N¼ 4) or mock infected
with knock down HCVcc (kd-HCVcc, N¼ 3) and subsequently were sampled and washed daily. RLU, relative luminescence unit. (D) Photograph showing location of surgical pocket
formation on murine left lateral lobe (left) and appearance following IH-ICC transplantation (right). The white dashed line depicts the capsular incision and the limits of the sub-
capsular scaffold implant are shown by the white arrows. Scale bar 1.5mm (E) H&E staining of explant reveals neo-vasculature of IH-ICC. Scale bar, 100 mm. (F) Immuno-
histochemical staining of explant for human albumin. Dashed white line indicates the boundary between implant and host liver. Scale bar, 100 mm. Mean ± sd; **p < 0.005,
****p < 0.0001, nd not detected. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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incapable of replication and acts as a negative control. Luciferase
signal was only detected in organoids inoculated with HCVcc cul-
tures, whilst 2D cells and kd-HCVcc inoculated samples failed to
exhibit detectable signal (Fig. 6C).
Having confirmed the organoid's preferential suitability for drug
metabolism and disease modelling we next sought to explore the
effects of in vivo transplantation. A pocket on the caudate lobe of
murine liver was created by making an incision in the liver capsule.
Organoids were placed into this pocket and sandwiched in place
between the left lobe and the lower lateral lobe in order to achieve
a bona fide homeostatic environment (Fig. 6D). After 4 weeks,
grafts were retrieved for further analysis. H&E staining revealed
implants were well integrated into the host parenchyma, without
evidence of significant fibrosis/inflammation whilst neo vasculari-
zation had successfully occurred between host and donor tissues
(Fig. 6E and Supplementary Fig. 20AeB). Histochemical staining
with human albumin confirmed the implanted structures were of
human origin, the organoid structure had remained intact and the
presence of human albumin in host serum suggested cells
remained functional (Fig. 6F and Supplementary Fig. 20CeE).3.5. TGFb and hedgehog signalling pathways are important for
organoid formation
To identify signalling pathways involved in the orchestration of
hepatic organoid formation, gene set enrichment analysis was
performed as described before. The top 15 gene sets uniquely
enriched in the ICC were related to metabolic/biosynthetic and
inflammatory/immune related processes (Fig. 7A). The enrichment
of bile acid metabolism, xenobiotic metabolism, fatty acid meta-
bolism, heme metabolism and cholesterol homeostasis are
encouraging signs of liver-specific organogenesis. Notably, three
highly conserved developmental pathways were identified through
this analysis e hedgehog, notch and TGFb. To confirm their func-
tional relevance, we treated organoids with small molecule in-
hibitors of hedgehog (Cyclopamine e CYC, 0.2 mM), notch (DAPT,
10 mM) and TGFbR-1 (RepSox, 12.5 mM) and characterized the
resultant effects on organoid formation. Morphological observa-
tions were also correlated with RT-qPCR evaluation of direct tran-
scriptional targets for each signalling pathway (Fig. 7B). Cells
managed to establish Phase I morphology (where cells lined up the
surface of ICC) regardless of the treatment. However, cells treated
with RepSox and CYC were unable to form typical organoid
Fig. 7. Mechanisms of organoid formation. (A) Bar chart detailing gene sets uniquely enriched in IH-ICC over 2D. (B) Gene expression (by RT-PCR) in IH-ICC of selected pathway
transcriptional targets, TGFb, Notch and Hedgehog (Hh) following addition of respective inhibitors (N¼ 4). (C) Confocal micrographs of IH in Phase II (CTNNB, green; CK19, red)
demonstrating effects of inhibitors on IH-ICC morphogenesis. Morphological quantification of observations provided on right. (D) Regulatory networks of TGFb (left) and hedgehog
(right). Genes labelled in red and green were identified as significantly up- and down regulated in IH-ICC over 2D. (E) Confocal micrographs showing translocation of phosphor-
SMAD2/3 and GLI1 in response to TGFb and hedgehog pathway activation in IH-ICC organoids. (F) Cell viability in IH-ICC as a consequence of adding each inhibitor as determined by
cell activity (N¼ 8). (G) Gene expression (by RT-PCR) of selected hepatic and biliary markers in IH-ICC following addition of each inhibitor above (N¼ 4). (H) Effect of inhibitors on
IH-ICC hepatic function by albumin production rate (N ¼ 4). Mean ± sd, *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001, ns nonsignificant. (For interpretation of the references
to colour in this figure legend, the reader is referred to the Web version of this article.)
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effect (Fig. 7C). RepSox treated cells arrested in Phase I of organo-
genesis resembling the observations seen with adult hepatocyte
and liver carcinoma cells (Supplementary Fig. 6). CYC treated cells
on the other hand, instead of transitioning into typical organoid
structures, formed much smaller clusters that were less uniform in
size and with a rougher surface. The regulatory network analysis on
TGFB and hedgehog signalling pathways revealed several upstream
ligands that are significantly up regulated in IH-ICC over 2D and
could potentially serve as the ligand for signalling activation
(Fig. 7D). The activation of these two pathways in IH-ICC were
further validated by the translocation of phopho-SMAD2/3 and zinc
finger GLI1 as shown in immunofluorescence staining (Fig. 7E and
Supplementary Fig. 21). To ensure cytotoxicity was not the causal
effect, the selected concentration of each inhibitor used was vali-
dated to have had minimal to no significant impact on cell viability
(Fig. 7F). Furthermore, the dramatic change in organogenesis
observed corresponded to a direct pathway effect (Fig. 7G), reduced
hepatic gene expression profile (Fig. 7F), and reduced albumin
production rate (Fig. 7H).
4. Discussion
Human organs exist in an incredible variety of shapes and sizes.
Understanding the processes through which these varied forms
arise during development, are maintained in homeostasis or
become perturbed during disease represent some of the most
fundamental questions facing us today in biology. iPSC-derived
cells provide an excellent model with which to study such ques-
tions through ex vivo formation of mini organs known as organo-
ids. iPSC-derived organoids are also highly appealing because they
themselves could be used for patient specific diseasemodelling and
therapy. Here we report a new approach to the generation of iPSC-
derived hepatic organoids, using state of the art bio-engineering
technology that by-passes the need for Matrigel and supporting
cell co-culture. Utility of this platform was demonstrated by our
findings in organoids of advanced hepatic function and dependence
on key developmental signalling pathways (Hedgehog and TGFb).
Ex vivo liver organogenesis is particularly challenging due to the
daunting complexity of the organ's structure and function. A
pivotal breakthrough in this field was made several years ago by
Takebe and colleagues when they generated hepatic organoids by
co-culturing iPSC-derived hepatic endoderm, HUVECs and MSCs in
Matrigel [1]. Immediate downstream translational applications are
potentially limited however by dependence upon non FDA-
compliant materials such as mouse-sarcoma-derived Matrigel
and the difficulty of scaling up productionwhen using multiple cell
types (MSCs & HUVECs) [6]. A more recent and equally exciting
organoid generation system, developed by Huch & Clevers [2], is
similarly limited by the need for Matrigel but also by its need for
primary tissue. In this study, we therefore sought to engineer liver
organoids free from Matrigel, MSCs, and HUVECs, using a 3D syn-
thetic hydrogel scaffold and hiPSC-derived hepatic progenitors
alone. To that end we developed a 3D scaffold called ICC (inverted
colloidal crystal) resembling the precise architectural microenvi-
ronment into which the liver diverticulum engages during liver bud
formation [15]. Due to the ICC's unique bottom-up fabrication
approach, we were able to custom engineer ‘cell-matrix’ in-
teractions through coating the inner lining of the ICC pores with
select ECM proteins [15] as well as custom engineer ‘cell-cell’ in-
teractions through manipulating pore size [8]. These engineering
designs cumulatively sought to recapitulate the extracellular niche
sensed by hepatic progenitors during bud formation. We observed
that the initial bud morphology, which we describe in this study as
Phase I organogenesis/budding, could only be achieved when twocritical factors weremet. First, presence of a suitable ECM coating to
facilitate cell attachment which otherwise fails due to the bioinert
property of the PEG from which the ICC is manufactured
(Fig. 2AeD). Second, seeding into a suitably sized pore, which
otherwise forces cells to clump rather than attach to the scaffold's
architecture if pore sizes are too small (Fig. 2EeH). Importantly, cell
condensation (as opposed to cell-ECM engagement) was associated
with down-regulation in hepatic gene expression, lower albumin
production rates and failure to progress to Phase II in which cells
lining the ICC self-organize into interconnected clusters to create a
homogenously repeating organoid tissue structure. This series of
morphogenic movements (Phase I/ Phase II) was unique to iPSC
(IH) and primary (fetal) hepatic progenitors and did not occur with
terminally differentiated adult cells or with cancer cell lines
(Supplementary Fig. 6) [21,22]. We therefore hypothesize our 3D
scaffolds leverage the intrinsic ability of liver stem/progenitor cells
to form organized structures in a manner which conserves the
interaction observed between progenitors and their surrounding
niche during organogenesis/budding [23].
As a consequence of this two-phase organogenesis/budding, the
ICC engineered organoids produce structures with progenitor cells
at the periphery and more mature cells in the middle. Such
arrangement is consistent with descriptions of early mammalian
liver development, where liver diverticulum progressing from
single cell lining to pseudostratified epithelium then three-
dimensional liver bud [25]. This bioengineering approach may
therefore provide a useful, but simplistic model to further our un-
derstanding of early liver development (budding) in vivo (Fig. 3A
and B). This configuration is in direct contrast to findings seenwith
spheroid/cell condensation culture systems where cells at the pe-
riphery are more viable and proliferative than cells at the core due
to hypoxia and DNA damage [26e29]. That difference underscores
the success of the engineering feat achieved here. The fact that liver
specific drug metabolism and disease modelling become upregu-
lated in parallel with these morphogenic changes along with the
capacity of the organoids to integrate, neo-vascularise and survive
in vivo emphasizes the physiological relevance of the tissue created
here (Figs. 4 and 5). How such morphogenesis and zonation is
programmed has been a long-standing question in biology. Our
initial interrogation suggests both the TGFb and hedgehog signal-
ling pathways to be pivotal in this regard. Hedgehog signalling is
particularly interesting in the context of liver zonation because it
has been reported to orchestrate the position of hepatocytes along
an oxygen gradient [24]. Our treatment of progenitors with a
hedgehog signalling pathway inhibitor, Cyclopamine, generated
not only smaller but dysmorphic organoids (Fig. 6C and D) and was
accompanied by downregulation of liver function (Fig. 6F and G).
These data suggest Hedgehog may be involved in much more than
simple cell positioning therefore.
To our knowledge, this is the first attempt to produce liver
organoids using just the combination of iPSC-derived hepatic
progenitors and a synthetic hydrogel. The unique modular features
of the ICC scaffold will allow study of the complex, combinatorial
influences of physical and chemical signals during liver organo-
genesis in a physiologically relevant, dissectible 3D microenviron-
ment. In addition, the scalable structure and clinically compliant
material (PEG) and cell lines [11] used, opens up the possibility of
future human therapy. These results highlight the enormous po-
tential of bioengineered organoids for discovery and translational
science.
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